Skip to main content
Article
The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases
American Journal of Surgery (2006)
  • Steve R. Martinez, Department of Surgical Oncology, Division of Gastrointestinal Surgery, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404, USA
  • Shawn E. Young, Department of Surgical Oncology, Division of Gastrointestinal Surgery, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404, USA
  • Armando E. Giuliano, The Joyce Keefer-Eisenberg Breast Center, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404, USA
  • Anton J. Bilchik, Department of Surgical Oncology, Division of Gastrointestinal Surgery, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404, USA
Publication Date
February 1, 2006
DOI
10.1016/j.amjsurg.2005.08.030
Citation Information
Steve R. Martinez, Shawn E. Young, Armando E. Giuliano and Anton J. Bilchik. "The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases" American Journal of Surgery Vol. 191 Iss. 2 (2006) p. 281 - 283
Available at: http://works.bepress.com/antonj-bilchik/142/